These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 690

  • 1. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U, Nürnberger H, Femmer K.
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract] [Full Text] [Related]

  • 2. [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)].
    Femmer K, Bartsch R, Leonhardt U, von Littrow C, Riedel H.
    Pharmazie; 1975 Oct; 30(10):642-51. PubMed ID: 688
    [No Abstract] [Full Text] [Related]

  • 3. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W, Wenzel A.
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract] [Full Text] [Related]

  • 4. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S, Femmer K.
    Pharmazie; 1980 Oct; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract] [Full Text] [Related]

  • 5. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 6. [Quantitative colorimetric determination of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert butylaminopropane (talinolol Cordanum, 02-115) in body fluids].
    Nürnberger H.
    Pharmazie; 1975 Oct; 30(10):673. PubMed ID: 693
    [No Abstract] [Full Text] [Related]

  • 7. [Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle].
    Bartsch R, Merbt EM, Riedel H.
    Pharmazie; 1975 Oct; 30(10):659-68. PubMed ID: 691
    [No Abstract] [Full Text] [Related]

  • 8. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K, Takami N, Ozaki M.
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [Abstract] [Full Text] [Related]

  • 9. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR, Pullman LG, Scholfield PC.
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [Abstract] [Full Text] [Related]

  • 10. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M, Trcka V, Helfert I.
    Acta Univ Carol Med (Praha); 1980 Nov; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract] [Full Text] [Related]

  • 11. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs].
    Femmer K, Klemm W, Nürnberger H.
    Pharmazie; 1975 Oct; 30(10):673-5. PubMed ID: 694
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R, Karim F, Stoker JB, Harry JD.
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract] [Full Text] [Related]

  • 16. Effects of selective and non-selective beta 1-blockade on renin secretion in the isolated rat kidney.
    Haro JM, Vargas F, Castillo MA, García-Torres L, Acuña D.
    Rev Esp Fisiol; 1989 Jun; 45(2):195-8. PubMed ID: 2570449
    [Abstract] [Full Text] [Related]

  • 17. Effect of beta-blocking agents in experimental atherosclerosis of cocks.
    Reinis Z, Lojda Z, Heyrovský A, Horáková D, Reisenauer R.
    Rev Czech Med; 1976 Jun; 22(3):117-26. PubMed ID: 9673
    [No Abstract] [Full Text] [Related]

  • 18. Bivalent ligand type beta-adrenolytics related to practolol.
    Rampa A, Da Re P, Valenti P, Frigeni V, Sala R, Della Bella D.
    Drugs Exp Clin Res; 1988 Jun; 14(9):581-6. PubMed ID: 2906585
    [Abstract] [Full Text] [Related]

  • 19. Assessment of effects of beta-blocking drugs on blood glucose levels and insulin hypoglycaemia in rats.
    Baird JR, Carter AJ.
    Eur J Pharmacol; 1974 Feb; 25(2):275-8. PubMed ID: 4154855
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.